ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $622,000 | -82.0% | 52,800 | -79.1% | 0.02% | -81.7% |
Q1 2019 | $3,456,000 | -9.3% | 253,200 | -31.9% | 0.12% | -18.4% |
Q4 2018 | $3,810,000 | -35.3% | 371,700 | +5.1% | 0.15% | -43.9% |
Q3 2018 | $5,889,000 | +383.9% | 353,700 | +359.4% | 0.26% | +297.0% |
Q2 2018 | $1,217,000 | -47.1% | 77,000 | -57.5% | 0.07% | -61.8% |
Q1 2018 | $2,301,000 | +272.9% | 181,234 | +236.5% | 0.17% | +170.3% |
Q2 2017 | $617,000 | -60.4% | 53,865 | -28.2% | 0.06% | -59.0% |
Q1 2017 | $1,560,000 | +411.5% | 75,000 | +704.6% | 0.16% | +200.0% |
Q3 2016 | $305,000 | +32.6% | 9,321 | +1.2% | 0.05% | +2.0% |
Q2 2016 | $230,000 | – | 9,215 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |